Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

New method boosts research efforts to eradicate cancer at its source

New method boosts research efforts to eradicate cancer at its source

Retroviruses invading the koala germline contribute to high cancer rates

Retroviruses invading the koala germline contribute to high cancer rates

Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer

Researchers urge European policymakers to make adequate resources available to tackle pancreatic cancer

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

Researchers evaluate frequency of SARS-CoV-2 in hematology/oncology settings

Researchers evaluate frequency of SARS-CoV-2 in hematology/oncology settings

Blood-clotting protein linked with tumor pathogenesis of CNS B-cell lymphoma

Blood-clotting protein linked with tumor pathogenesis of CNS B-cell lymphoma

A new method for controlling leukemic stem cells

A new method for controlling leukemic stem cells

Scientists discover two unique subtypes of a prominent mutation in patients with AML

Scientists discover two unique subtypes of a prominent mutation in patients with AML

What are the changes in the physical phenotype of blood cells in COVID-19?

What are the changes in the physical phenotype of blood cells in COVID-19?

Scientists characterize genomic profile of 84 pediatric therapy-related myeloid neoplasms

Scientists characterize genomic profile of 84 pediatric therapy-related myeloid neoplasms

Researchers identify a pathway used by filoviruses to enter cells

Researchers identify a pathway used by filoviruses to enter cells

Scientists conduct interdisciplinary study on using nanoparticles to fight leukemia

Scientists conduct interdisciplinary study on using nanoparticles to fight leukemia

Single strain of bacteria may reduce the severity of graft-versus-host disease

Single strain of bacteria may reduce the severity of graft-versus-host disease

Study provides new insights into the mechanism of bone marrow tissue

Study provides new insights into the mechanism of bone marrow tissue

New drug candidate to be trialed for most lethal form of brain cancer

New drug candidate to be trialed for most lethal form of brain cancer

Gene mutations may explain the poorer outcomes in Hispanic and Latino children with leukemia

Gene mutations may explain the poorer outcomes in Hispanic and Latino children with leukemia

Researchers find possible cause for self-destructive immune system attacks in autoimmune diseases

Researchers find possible cause for self-destructive immune system attacks in autoimmune diseases

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.